A practical reference on REV-ERB agonist: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-02-05 and is reviewed periodically as new material appears.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water; stock solutions use organic solvent. |
| Storage | -20°C, desiccated, protected from light | Limits hydrolysis and photodegradation. |
| Analytical method | HPLC-UV/MS | Used for identity and purity assessment. |
| Synonyms | SR9009, Stenabolic | Naming varies by supplier. |
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
For prolonged treatment of lupus or rheumatoid arthritis, adverse effects include the acute symptoms, plus altered eye pigmentation, acne, anemia, bleaching of hair, blisters in mouth and eyes, blood disorders, cardiomyopathy, convulsions, vision difficulties, diminished reflexes, emotional changes, excessive coloring of the skin, hearing loss, hives, itching, liver problems or liver failure, loss of hair, muscle paralysis, weakness or atrophy, nightmares, psoriasis, reading difficulties, tinnitus, skin inflammation and scaling, skin rash, vertigo, weight loss, and occasionally urinary incontinence. Hydroxychloroquine can worsen existing cases of both psoriasis and porphyria. Children may be especially vulnerable to developing adverse effects from hydroxychloroquine overdoses.
As skin ages, it becomes thinner and more easily damaged. Intensifying this effect is the decreasing ability of skin to heal itself as a person ages. Among other things, skin ageing is noted by a decrease in volume and elasticity. There are many internal and external causes to skin ageing. For example, ageing skin receives less blood flow and lower glandular activity. A validated comprehensive grading scale has categorized the clinical findings of skin ageing as laxity (sagging), rhytids (wrinkles), and the various facets of photoageing, including erythema (redness), and telangiectasia, dyspigmentation (brown discolouration), solar elastosis (yellowing), keratoses (abnormal growths) and poor texture. Cortisol causes degradation of collagen, accelerating skin ageing. Anti-ageing supplements are used to treat skin ageing.
== Structure == The territorial matrix is composed of collagen fibrils and proteoglycans, forming a dense matrix around groups of chondrocytes, distinguishing itself from neighboring zones. It is located between the pericellular and interterritorial matrix. The territorial matrix is smaller in size (5-10 μm) than the interterritorial matrix, but larger than the pericellular matrix., The collagen that exists in this region is primarily type II collagen, with some types IX and XI. It is arranged in a finer, more interwoven network than in the interterritorial matrix. Proteoglycans like aggrecan and decorin provide resistance to compressive loads. Several glycoproteins are also present and play roles in the matrix assembly and stabilization. The close packing of the fibrils make the region denser, forming a mechanical barrier around chondrocytes.
Sources: en.wikipedia.org
=== Types of microneedle === There are many types of microneedle that are distinguished by the shape and other characteristics. The types include: Dissolvable MNPs, solid non-soluble MNPs, and hollow MNPs. Different MNPs may be chosen depending on the situation and the drug properties.
=== Cations and carbonylates === The synthesis of ionic carbonyl complexes is possible by oxidation or reduction of the neutral complexes. Anionic metal carbonylates can be obtained for example by reduction of dinuclear complexes with sodium. A familiar example is the sodium salt of iron tetracarbonylate (Na2Fe(CO)4, Collman's reagent), which is used in organic synthesis. The cationic hexacarbonyl salts of manganese, technetium and rhenium can be prepared from the carbonyl halides under carbon monoxide pressure by reaction with a Lewis acid.
== References == Fonseca, Jorge M.; High Relative Humidity; Fresh Americas, #1, 2008 Series, Master Media Worldwide Publishing Devon Zagory, Devon Zagory & Associates, University of California, Davis; Advances In Modified Atmosphere Packaging (MAP) of Fresh Produce; Perishables Handling Newsletter Issue No. 90, May 1997, pages 2–3 N. Aharoni, V. Rodov, E. Fallik, R. Porat, E. Pesis and S. Lurie; Department of Postharvest Science of Fresh Produce, ARO, The Volcani Center; Humidity Improves Efficacy of Modified Atmosphere Packaging of Fruits and Vegetables Adel A. Kader, Dept. of Pomology University of California, Davis; Modified Atmosphere Packaging of Fresh Produce; Outlook Second Quarter, Volume 13, No. 2, 1986 Stephen R. Harris; Storage of fresh produce Food and Agriculture Organization of the United Nations; Production is only Half the Battle – A training manual in fresh produce marketing for the Eastern Caribbean, Chapter 8: Storage of fresh produce; Bridgetown, Barbados, December 1988
==== Capillary action ==== Capillary forces determine the movements (or absence of movement) of free water. It is due to both adhesion and cohesion. Adhesion is the attraction between water to other substances and cohesion is the attraction of the molecules in water to each other. As wood dries, evaporation of water from the surface sets up capillary forces that exert a pull on the free water in the zones of wood beneath the surfaces. When there is no longer any free water in the wood capillary forces are no longer of importance.
Sources: en.wikipedia.org
== Welfare considerations during farmed insect rearing == As with other livestock animals, a variety of welfare concerns can manifest during the rearing and slaughter of insects. The 5 Domains framework can be used to broadly categorize these areas of possible concern into four functional domains (nutrition, environment, behavior, and physical health) which then influence the mental domain of the animal's welfare state. As the insect industry is very new, and there are few animal welfare scientists dedicated to studying its livestock, there is little guidance or infrastructure dedicated to improving farmed insect welfare. Further, just as with farmed vertebrates, species-specific guidance is needed to maintain high welfare for each species of insects that is farmed. Recently, several comprehensive and open access review papers have been published that cover the likely welfare concerns for black soldier flies (Hermetia illucens), yellow mealworms (Tenebrio molitor), and three species of farmed crickets (Acheta domesticus, Gryllus bimaculatus, Gryllodes sigillatus), as well as some work on the housefly (Musca domestica). The major, currently known areas of welfare concern during rearing are organized below by functional domain and largely focus on the most farmed insects: black soldier flies, yellow mealworms, and farmed crickets.
== History == The company was incorporated in January 2006 as Phluid, Inc. and changed its name to Tandem Diabetes Care in 2008. Former Biosite executive Kim Blickenstaff joined as president and chief executive officer in 2007. Its first product was designed following interviews with pump users and clinicians and used a color touchscreen rather than the button-based interfaces then common on insulin pumps. The Food and Drug Administration (FDA) cleared the t:slim insulin-delivery system in November 2011, and Tandem began selling it in the United States the following year. In November 2013, Tandem sold eight million shares at $15 each in its initial public offering, raising approximately $108 million after costs. Tandem began shipping the software-updatable t:slim X2 in 2016. The FDA subsequently authorized versions that displayed readings from the Dexcom G5 and G6 CGMs, and in 2019 classified the t:slim X2 as the first alternate controller enabled insulin pump, a category designed to support interoperable diabetes devices. John Sheridan, previously the company's chief operating officer, succeeded Blickenstaff as president and CEO in March 2019. The company acquired the diabetes-data application Sugarmate in June 2020. It acquired infusion-set developer Capillary Biomedical for $24.7 million in July 2022 and Swiss patch-pump developer AMF Medical in January 2023. AMF had been developing Sigi, a rechargeable patch pump that used prefilled insulin cartridges; the product remained in development at the end of 2025.
=== Geelong Football Club (2000–2010) === Thompson was appointed as Geelong Football Club senior coach at the end of the 1999 season, for the 2000 season when he replaced Gary Ayres, who quit as Geelong Football Club senior coach. Thompson as Geelong Football Club senior coach was given an extended time to rebuild the club's playing list. Geelong under Thompson finished 5th in the 2000 season in his first season as senior coach but was eliminated by 8th placed Hawthorn in the first week of the finals in the first finals match ever held at the Docklands Stadium. The club under Thompson performed poorly for the next three seasons from 2001 until 2003, missing the top 8 and not making the finals. Thompson's position looked in danger, but in the 2004 season, Geelong under Thompson was a big improver, finishing fourth and making the Preliminary Finals, losing to eventual runners-up Brisbane Lions. Due to his success in reinvigorating the club, Thompson's contract was extended until 2007. The following year in the 2005 season, the club under Thompson finished sixth and was beaten in the Semi-Finals by 3 points against the eventual premiers Sydney Swans after leading for the majority of the match. In the 2006 season, however the club under Thompson eventually missed the finals after winning the NAB Cup and winning their first two matches in convincing style, leading them into flag favouritism. It was also a season where Thompson had used the 2005 semi-final loss to the Swans as motivation.
is the mean square radius of branched and linear macromolecules with identical molar masses. By utilizing MALS in conjunction with a concentration detector as described above, one create a log-log plot of the root-mean-square radius vs molar mass. The slope of this plot yields the branching ratio, g. In addition to branching, the log-log plot of size vs. molar mass indicates the shape or conformation of a macromolecule. An increase in the slope of the plot indicates a variation in conformation of a polymer from spherical to random coil to linear. Combining the mean-square radius from MALS with the hydrodynamic radius
==== Secondary-Ion MS ==== SIMS is a micro-analytical technique valuable for three-dimensional analysis of a materials elemental composition and isotopic ratios. This method can be utilized in characterization of bulk materials with a detection limit in the low parts per billion (10−9 or ng/g) range. Particles as small as a few hundreds of nanometers can be detected. Ion production in this technique is dependent on the bombardment of solid samples with a focused beam of primary ions. The sputtered, secondary ions are directed onto the mass spectrometry system to be measured. The secondary ions are a result of kinetic energy transfer from the primary ions. These primary ions penetrate into the solid sample to some depth. This method can be used to detect any element, however the sputtering process is highly matrix dependent and ion yields vary. This method is especially useful, because it can be fully automated to find uranium particles in a sample of many million particles in a matter of hours. Particles of interest can then be imaged and further analyzed with very high isotopic precision.
Sources: en.wikipedia.org
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.
The solid is generally kept cold, dry, and protected from light. Solutions are often frozen in single-use aliquots to reduce repeated freeze-thaw cycles.
It indicates a material sold for laboratory study, not for human use. The label does not guarantee pharmaceutical purity, sterility, or regulatory approval.
It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.